Fusion Antibodies plc, a contract research organization, engages in the research, development, and manufacture of recombinant proteins and antibodies for cancer and infectious diseases in the United Kingdom, the rest of Europe, North America, and internationally. The company offers monoclonal antibo... Fusion Antibodies plc, a contract research organization, engages in the research, development, and manufacture of recombinant proteins and antibodies for cancer and infectious diseases in the United Kingdom, the rest of Europe, North America, and internationally. The company offers monoclonal antibody discovery and development, antibody sequencing, antibody engineering, antibody humanization and rational affinity maturation platform, recombinant protein expression, and stable cell line development and cGMP scale up services. It serves pharmaceutical, biotech, veterinary, diagnostic, and life science research companies. The company has a collaboration agreement with the National Cancer Institute for the use of OptiMAL. Fusion Antibodies plc was incorporated in 2000 and is based in Belfast, the United Kingdom. 詳細を表示
| 期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 12.5 | 13.025 | 12 | 386865 | 12.77629742 | DE |
| 4 | -2 | -13.7931034483 | 14.5 | 15.25 | 12 | 333263 | 13.26594891 | DE |
| 12 | 0 | 0 | 12.5 | 15.5 | 10.75 | 484235 | 13.12816535 | DE |
| 26 | -2.75 | -18.0327868852 | 15.25 | 19.75 | 10.75 | 603951 | 14.35483172 | DE |
| 52 | 5.85 | 87.969924812 | 6.65 | 20.5 | 6.1 | 870034 | 13.46670105 | DE |
| 156 | 5.75 | 85.1851851852 | 6.75 | 20.5 | 2.9 | 1082759 | 7.79176275 | DE |
| 260 | -120 | -90.5660377358 | 132.5 | 142.5 | 2.9 | 691531 | 8.50530727 | DE |
UPMI
5分前
jour_trader
5分前
bb8675309
6分前
bananarama
9分前
chazzy1
10分前
EOT
12分前
HoldHigh
13分前
Mark
16分前
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
すでにアカウントをお持ちですか? サインイン
アカウントをお持ちでないですか? 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。